Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

cc-TDI Aims to Deliver Five Childhood Cancer Therapy Drugs to Clinical Trial Each Year

Children's Cancer Therapy Development Institute

The Children’s Cancer Therapy Development Institute (cc-TDI), a non-profit organization focused on the ‘preclinical gap’ in childhood cancer research, announced its goal to deliver five drugs to clinical trial each year. Founded in 2015, the nonprofit continues to address a pressing need that receives little attention—a lack of advancement in treatment options for children living with cancer. The lab’s aim is to make childhood cancer universally survivable, regardless of diagnosis. “For many forms of childhood cancer, we’ve seen little to no advancement in treatment options in the past few decades,” said Charles Keller, Scientific Director at cc-TDI. “We have embarked upon a mission to send more targeted drugs into clinical trials for those childhood cancers that need our help the most.” Since its inception, cc-TDI has delivered two drugs from publications into three clinical trials for childhood brain tumors and sarcomas and are in the midst of four promising research projects addressing rhabdomyosarcoma, medulloblastoma, and other brain tumors and sarcomas – on a two-million-dollar budget. Only 4% of the billions of dollars spent on cancer research annually is allocated for childhood cancer research. Since 1978, only 11 drugs have been FDA approved to be used in childhood cancer treatment, compared to an average of 12 adult drugs approved annually. Alarmingly, 80% of kids who survive their cancer diagnosis live with lifelong side effects from the toxic drugs used in their treatment, made for adults. “Grassroots labs like cc-TDI are important because we are researching less toxic drugs that will produce fewer side effects on kids and increase their quality of life through survivorship,” said Keller. “Simply put, children and families deserve a research approach that is just as aggressive as the cancers they are fighting.” By focusing its time, energy, and talents on filling the pre-clinical trial gap, cc-TDI can control which childhood cancer treatments advance to clinical trials. For more information on cc-TDI and how you can help, please visit www.cc-tdi.org. About Children's Cancer Therapy Development Institute Children’s Cancer Therapy Development Institute (cc-TDI) is a unique non-profit organization focused on the ‘preclinical gap’ in childhood cancer research. Our mission is to bridge scientific discovery and the initiation of clinical trials. The cc-TDI research team is led by Scientific Director Dr. Charles Keller who follows in the footsteps of his mentor, 2007 Nobel laureate Mario Capecchi. The cc-TDI laboratory is based on the premise of a non-profit multidisciplinary biotech and is thus located in between the Silicon Forest in Beaverton, OR (Intel Headquarters) and the Portland-area medical center. Learn more about cc-TDI by visiting www.cc-tdi.org. Contact Details cc-TDI Bree Thompson +1 503-985-6016 bree@cc-tdi.org Company Website https://www.cc-tdi.org

February 16, 2021 09:10 AM Eastern Standard Time

OZETTE RAISES $6M SEED ROUND FOR AI-POWERED IMMUNE MONITORING PLATFORM

Ozette

Ozette, creators of a cutting edge artificial intelligence-powered Immune Monitoring Platform, today announced $6 million in seed financing led by Madrona Venture Group, with participation from Allen Institute for Artificial Intelligence (AI2) and Vulcan Capital. Ozette, a collaboration between the Fred Hutchinson Cancer Research Center and AI2, will use the seed funding to accelerate breakthroughs in treating disease. The co-founders of Ozette include Scientific Founder Raphael Gottardo and Chief Technology Officer Greg Finak, who are recognized leaders in single-cell analysis and who have taken a crucial step in biomarker and drug discovery research, driving new therapies. “We’ve spent a decade working at Fred Hutch to catalyze high-dimensional computational single-cell analysis in academia and industry. Today we can see the composition of the immune system at a much higher resolution,” said Greg Finak, Co-Founder and CTO at Ozette. “This deeper level of insight is critical to developing effective disease treatments with fewer side effects and that is something everyone can feel good about.” WHY OZETTE MATTERS Ozette’s Immune Monitoring Platform enables scientists to quickly extract reliable insights from single-cell data across instruments, experiments and disease states. Having this fully annotated data allows interpretable results for critical decision-making that will improve patient care and patient outcomes. Ultimately, Ozette will revolutionize the next phase of medicine by: Providing the platform to empower scientists who are working with single-cell data. Automating the manual, labor-intensive process of cell analysis from months of work to just hours. Unlocking personalized medicine through targeted therapies based on the profiles of individuals’ immune systems. “What Ozette is delivering to science and medicine is game-changing because it sheds light on the entire cell profile of the immune system, not just only a small percentage of it,” said Matt McIlwain, Managing Director at Madrona. “Ozette brings together the power of computational biology and data science to the life sciences by building a platform that researchers, academics, and biopharmaceutical companies are able to leverage to find treatments faster than ever before.” “Think of the Ozette Immune Monitoring Platform like an MRI for the immune system,” said Dr. Ali Ansary, Co-Founder and CEO of Ozette. “Where an MRI shows detailed images around the anatomical structures, our technology delivers a high-resolution view of the immune system at the single-cell level, providing details that haven’t been visible before. This makes treatments safer, faster to develop and personalized for patients.” “At AI2 we are constantly looking for scientific potential in artificial intelligence that has the power to improve daily lives, and Ozette does just that,” said Professor Oren Etzioni, CEO of AI2. “Ozette’s Immune Monitoring Platform is exactly what scientists and researchers have been looking for. By allowing organizations to make discoveries faster, and with less risk, it will transform how we interact with medicine.” For more information about Ozette, please visit www.ozette.ai or follow Ozette on Twitter and LinkedIn. About Ozette Ozette is a Seattle-based life-sciences data spin-out founded in 2020 and incubated at AI2. Ozette is building a groundbreaking high-resolution immune monitoring platform powered by innovative technologies developed at the Fred Hutch. Ozette’s founders include Fred Hutch scientists Raphael Gottardo, Greg Finak and Evan Greene, who have helped pioneer single-cell computational analysis over the past decade, along with physician and entrepreneur Ali Ansary. About the Allen Institute for AI (AI2) AI2 was founded in 2014 with the singular focus of conducting high-impact research and engineering in the field of artificial intelligence, all for the common good. AI2 is the creation of Paul Allen, Microsoft co-founder, and is led by Dr. Oren Etzioni, a leading researcher in the field of AI. AI2 employs more than 100 top-notch researchers and engineers from across the globe. AI2 prides itself on the diversity and collaboration of our team and takes a results-oriented approach to complex challenges in AI. Learn more at allenai.org. About Madrona Madrona ( www.madrona.com ) is a venture capital firm based in Seattle, WA. With more than 25 years of investing in early-stage technology companies, the firm has worked with founders from Day One to help build their company for the long run. Madrona invests predominantly in seed and Series A rounds across the information technology spectrum, and in 2018 raised the first fund dedicated to initial investments in acceleration stage (Series B and C stages) companies. Madrona manages over $2 billion and was an early investor in companies such as Amazon, Smartsheet, Isilon, Redfin, and Snowflake. About Vulcan Capital Vulcan Capital is the multi-billion-dollar investment arm of Vulcan Inc., the company founded by Microsoft co-founder and philanthropist Paul G. Allen. Vulcan Capital is focused on generating long-term value appreciation across a portfolio which spans diverse industry sectors and investment asset classes, ranging from early-stage venture investments to public equity value investing, leveraged buyouts, acquisitions, special situations and fixed income. Vulcan Capital was formed in 2003 and is headquartered in Seattle with additional offices in Palo Alto and Singapore. Contact Details Owen Media Faith Brewitt +1 603-686-0913 faith@owenmedia.com Company Website https://www.ozette.ai

February 16, 2021 08:03 AM Eastern Standard Time

Breakthrough Rapid-Action Coronavirus and Bacteria Disinfection Technology for Passenger Luggage at Airports Stops Local Outbreaks from Becoming Global Pandemics

WarpUV

We are all familiar with the x-ray machines that provide traveler security at every airport in the world. Now, imagine comparable machines that provide 99.99% disinfection from current and future viruses on carry-on and checked bags, including the SARS-CoV-2 Coronavirus, COVID-19, and unpredictable mutations, as well as bacteria and spores. In 2021, biohazard disinfection startup WarpUV® will deliver just such a machine, known as AirFort ®, to airports, putting the company at the forefront of preventing present and future global pandemics and serving as a “disinfection firewall” that will contain the spread of contagions from the common cold and seasonal influenzas to deadly viruses, including the newly identified B.1.1.7 COVID-19 mutation recently discovered in the United Kingdom and the 501.V2 strain, which is spreading like wildfire across the world. In less than 30 seconds the multi patent-pending WarpUV AirFort machines rapidly disinfect all surface contamination from carry-on and checked bags, personal items and oversized bags and parcels before they enter an airport concourse or the plane’s cargo hold – both for incoming and outgoing flights -- ensuring passenger safety from a broad spectrum of pathogens. AirFort utilizes a proprietary 3-D array of ultraviolet lights designed to achieve all-angle “360° x 360°” disinfection of all baggage surfaces. The machines were designed with airports and airlines in mind and integrate seamlessly into airport operations, even during periods of high footfall traffic. Such biosecurity is urgently needed to contain the spread of rapidly emerging Sars-CoV-2 coronavirus variants that are more contagious or can prolong the pandemic. With research indicating that fighting COVID-19 could cost 500 times as much as pandemic prevention measures, World Health Organization (WHO) senior advisor Bruce Aylward warned earlier this year that “We need to get ready for something that may even be more severe in the future.” Background, Resources & Stats: The COVID-19 pandemic has been and will remain costly, with experts predicting it may be with us for at least 10 years. During that timeframe, other virus and flu strains likely will emerge, exacerbating the need for travel solutions that help stop their spread. According to the University of Cambridge (England), the global economy could take a hit of some $82 trillion over the next five years in a worst-case scenario from the COVID-19 pandemic, adding that if the recovery is faster, an "optimistic loss" of $3.3 trillion is likely. The COVID-19 vaccine is not a panacea. Ugar Sahin, BioNTech CEO, reported the deadly virus is going to stay with us for the next decade at least. According to AirportWatch, global air traffic dropped by 60% in 2020 amid travel restrictions due to COVID-19. With more than 17,500 commercial airports globally serving more than 925 million passengers on nearly 39 million flights in 2019, and with each passenger carrying one or two pieces of luggage onto planes annually, air travel remains one of the most vulnerable means for spreading airborne infectious diseases. “Airport biosecurity has become an urgent and critical staple of airport security since the COVID-19 containment shut down the vast majority of air traffic, introducing global economic fragility and disrupting mobility,” said WarpUV CEO Amir Fischer, a serial entrepreneur who spent four years in airline and airport security at London Heathrow airport. “With AirFort, airports and airlines can restore passenger safety and help prevent future local outbreaks before they become global pandemics.” WarpUV sees enormous market potential for AirFort, and the company will scale up quickly. A WarpUV proof-of-concept device is already deployed for efficacy testing at Tel Aviv University’s Shmunis School of Biomedicine and Cancer Research, at the Microbial Pathogenesis Laboratory headed by world-renowned microbiologist Prof. Anat Herskovits. “We are already seeing conclusive confirmation that the WarpUV device achieves rapid and comprehensive disinfection of Corona viruses, as well as other viruses and bacteria,” Prof. Herskovits said. She also serves as WarpUV’s head of microbiology. WarpUV’s business model uses a modest ticket surcharge in lieu of burdening airport authorities with capital expenditures. Airports briefed on the devices have expressed a great deal of interest in WarpUV. With access to nearly one hundred airports via two leading industry distributors, WarpUV already has deals underway representing more than $100 million in revenue. About WarpUV Warp Technologies and it’s AirFort® devices are the frontline of prevention of the spread of pandemic by luggage and baggage in airports worldwide and serve as a “disinfection firewall” for continents, countries, and regions. The company was formed in 2020 by veteran Israeli entrepreneurs Amir Fischer, Eitan Haimovich, and Gil Luxenbourg. For more information, visit www.warpUV.com. Contact Details Rainier Communications Alan Ryan +1 508-577-6635 alanryan@rainierco.com Rainier Communications Joanne Stanway +1 978-273-1473 jstanway@rainierco.com Company Website https://www.warpuv.com

February 16, 2021 07:57 AM Eastern Standard Time

Video

Knowledgehook to boost maths attainment across Australia

Stockwood Strategy

Knowledgehook, the world’s most comprehensive mathematics learning platform, has launched in Australia as the nation’s teachers turn a corner in addressing low maths attainment levels for young people. It is now available to schools across the country for children in Year 3 to Year 10 classes, through The Learner First, a consultancy working with schools across Australia. The latest TIMSS (Trends in International Mathematics and Science Study) found that Australia’s achievement in mathematics has improved since 2015. However, Year 4 mathematics achievement has not changed since 2007. One of the biggest challenges facing educators is to find better ways to meet the learning needs of the many students who fall behind in schools, failing to meet year-level expectations (often year after year) and, as a consequence, become increasingly disengaged. Knowledgehook’s proprietary technology harnesses the power of data to track where students are on their math journey. Their programmes connect a child’s at-home learning with in-school education, providing real-time insights to teachers on learning gaps. This empowers teachers to develop an understanding of the maths concepts related to their students’ challenges, enabling them to adjust instruction and monitor student progress. As Knowledgehook launches across Australia, former Australian Mathematics Curriculum leader, Margaret Bigelow, commented: " Australia's results in international testing are improving. The impact of a national approach to teaching and learning Mathematics has impacted on this improved outcome. Teachers need to be supported to maintain this trajectory of improvement by having the ideas and tools to enhance the engagement of their students to develop critical and creative thinking and further mathematical skills. This will enable students to adjust to the ever-changing demands and challenges of life in the future." “Knowledgehook was inspired by my own struggle with maths as a child,'' explained Co-Founder and CEO of Knowledgehook, Travis Ratnam. “Having the right, personalised guidance makes all the difference and every student deserves to have a teacher who has access to the best pedagogical tools, and parents who have insights into their learning. Our platform is not a game, it pulls together a 360 view on a child’s learning journey enabling people around them to improve the child’s math experience and outcomes. In launching Knowledgehook across Australia, Joanne McEachen, Founder and CEO of The Learner First commented: “I love the fact maths support is available 24/7 so when a learner struggles with a math’s concept, the teacher can access professional learning and development to help support both the learner and the teacher on the spot. Moreover, it helps teachers retrace their approach and identifies what may have been missed allowing them to recover and embed essential skills and concepts. Quite simply, it is what we have been missing for years and it will certainly complement the current trajectory of further improving math’s performance and disposition in Australian students.” Knowledgehook’s AI-enabled platform has grown to support schools across the US, Mexico, and the UK. It is designed to scale across multiple countries and languages developing teacher capacity while engaging students and providing actionable insights for parents. Over the years, Knowledgehook’s research-based solution has garnered industry-leading partnerships and investments from the most recognised global education bodies, notably from the University College of London (UCL), the global leader in education research. Knowledgehook actively collaborates with governments around the world while also working directly with schools and their suppliers, to offer curriculum-aligned solutions. The company currently empowers teachers in more than 100,000 schools. In 2021, it is anticipated the solution will reach 50,000,000 students globally. “We have received growing interest for our technology and expertise to be applied to other subjects and we look forward to expanding our solution to empower more educators and support the learning of students to become the problem-solvers of tomorrow,” Qamar Qureshi, President and Chief Business Officer added. Ends About Knowledgehook Knowledgehook, a leading educational technology company, empowers hundreds of thousands of teachers and parents to collaboratively support the mathematics learning journey of millions of students worldwide. Winner of Google’s Game Changer Award and named Top Disruptor by BNN, its platform analyses student understanding through engaging assessments, providing real-time personalised solutions to close learning gaps between classroom teaching and at-home learning. Designed by leading numeracy and research experts, Knowledgehook’s Instructional Guidance System is known for reinventing how online technology supports education and educators, while inspiring the problem solvers of tomorrow. Contact Details Knowledgehook Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.knowledgehook.com/

February 15, 2021 04:00 PM Eastern Standard Time

Image

The U.S. Chamber Discover & Deliver initiative is Fighting Covid-19 with Innovation and Technology

YourUpdateTV

Defeating the global pandemic is truly an all-of-nation effort. Across the nation, America’s innovation community has mobilized like never before to fight the coronavirus pandemic. Right now, our nation’s brightest scientific minds, most innovative companies, and leading universities are moving at unprecedented speed to deliver the COVID-19 treatments, vaccines, diagnostics, and cures we need. The scope is as impressive as the speed. To date, scientists are conducting over a thousand clinical trials in the United States for potential pandemic ending solutions, in all 50 states, from big cities to small towns. The U.S. Chamber Discover & Deliver initiative is telling the story about the private sector’s role in bringing the science to life and bringing it to people. It is a nationwide, cross-industry effort that involves our brightest scientific minds, the most innovative companies, and the nation’s leading universities—all working together toward the common goal of leading the global community out of this crisis. Discover & Deliver is conducting virtual events in communities across the United States to engage local leaders, share the latest information, and provide a “boots on the ground” view of progress underway. To help illustrate this story, the U.S. developed an interactive map, to show what’s happening across our country—in communities large and small—as innovation works to identify the solutions we need to solve the coronavirus pandemic. Visit www.USChamber.com for the latest resources and insights into the all-of-nation effort underway to beat this pandemic. About YourUpdateTV: YourUpdateTV is a social media video portal for organizations to share their content. It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

February 11, 2021 01:00 PM Eastern Standard Time

Kaia Health unveils complete musculoskeletal care solution with Kaia Gateway and Premium Partners

Kaia Health

Digital therapeutic company, Kaia Health, unveils the next-generation, complete musculoskeletal (MSK) care solution for employers and health plans. Kaia Gateway will include a case review service and clinical triage algorithms, while Kaia Premium Partners will provide native interoperability with select providers - all within Kaia’s existing solution. The new treatment concept is based on what Kaia has already evaluated in the industry’s largest randomized controlled trial (RCT). Kaia’s next generation offering also expands support to chronic, acute, and presurgery care for back, neck, hip, knee, shoulder, hand/wrist, and foot/ankle pain. All this is backed by Kaia’s claims-based 2:1 ROI guarantee. Up until today, Kaia Health’s digital MSK program has treated 450,000 patients with evidence-based care. Kaia Health’s MSK app features patented Motion Coach™ computer vision technology, which tracks the body by measuring thousands of data points every minute during exercising and a functional movement test. It provides ongoing support and real-time, automated PT-grade exercise feedback, creating a more personalized, effective, and engaging experience than sensor straps or tele-PT video calls once per month. Introducing the all-new Kaia Gateway Accessed via Kaia Health’s existing digital MSK program, Kaia Gateway will be the new front door for all MSK patients. Each will be screened using a clinical triage algorithm, which analyzes various clinical dimensions to identify patients at risk of needing more invasive or intense treatment. Those with medical issues, or likely to elect into surgery, will be directed to a Kaia Health medical provider for further consultation. An AI-enabled escalation algorithm will monitor patients longitudinally for clinical and behavioral patterns that might warrant an intervention by a Kaia Health medical professional or health coach. Integrating a case review service will reduce costs, as the likelihood of unnecessary elective surgery varies drastically depending on whom patients speak with first¹. “Kaia Gateway creates an unprecedented level of understanding of MSK patients and their progression,” says Justin Yang, Kaia Health’s U.S. Chief Medical Officer. “The algorithms now include Motion Coach™ data in addition to self-reported and adherence data. The Motion Coach™ insights thus now drive our clinical decision making in addition to patient engagement. This richer dataset will offer a more informed user case review and allow Kaia Gateway to make better patient choices in the treatment app or via one of our partners.” Introducing Premium Partners Already today, Kaia Health coaches refer out to other medical services in an employer or health plan’s ecosystem using pathways configured during implementation. Premium Partners will take this one stage further and set a new precedent for employee benefits interoperability by offering the most sophisticated integration option available in the MSK market. Premium Partners will have access to detailed treatment history including insights from Motion Coach™, disease progression, exercise level information, and medical surveys. Kaia has already built out bi-directional referrals and warm transfers, single sign-on capability, incentive program integrations and automated data exchange APIs with first Premium Partners. Additional Premium Partners offerings include other evaluated general and specialty care solutions, such as digital interventions, disease management programs, PT, telemedicine, care navigation, and expert medical opinion services. “Kaia Health is the next-generation MSK solution to integrate with the existing care landscape, one that addresses MSK cases across an expanded MSK care spectrum,” says Jonas Duss, Kaia Health’s U.S. CEO. “Our goal is to create a happier, healthier and less-costly workforce together with our Premium Partners.” Kaia Health has among the industry’s most robust clinical evidence with the largest published randomized control trial [ source ], and a rigorous claims-based ROI methodology [ source ]. In a recent regional health system deployment, Kaia Health’s MSK app use resulted in a 22% medical claims net cost saving and a 50% decrease in MSK pain level. For employers, Kaia Health’s MSK app has demonstrated a more than 20% decrease in medical spend with a 1.6x - 3x average ROI in the first year [ source ]. MSK conditions affect 126.6 million Americans², which results in annual costs to U.S. employers of $120 billion ³. MSK conditions cost businesses an average of $425 per employee per year⁴ in medical bills, affect 25% of their workforce and account for 16% of overall medical spend. Most of Kaia’s next generation solution will be available starting Q3 2021 with Kaia Gateway (Case Review service, Triage & Escalation algorithms, and expanded joint coverage). Premium Partners will be rolling out on an ongoing basis. The preventative program will conclude the rollout on January 1, 2022. ENDS Media interviews Jonas Duss, Kaia Health’s U.S. CEO, and Justin Yang, Kaia Health’s U.S. Chief Medical Officer, are available for interview References 1. Lenza M, Buchbinder R, Staples MP, et al. Second opinion for degenerative spinal conditions: an option or a necessity? A prospective observational study. BMC Musculoskelet Disord. 2017;18(1):354. 2. American Academy of Orthopaedic Surgeons (2016): One in two Americans have a musculoskeletal condition 3. Northeast Business Group on Health (2017): Preventing and Treating Musculoskeletal Disorders: New Strategies for Employers 4. Source: internal data received by Kaia from 130+ large employers About Kaia Health Kaia Health is a digital therapeutics company that creates accessible, evidence-based treatments for a range of disorders including back pain, COPD and osteoarthritis. Working with experts in various medical fields, the company uses machine learning to deliver individualised app interventions that aim to empower and motivate patients to take control and self-manage their condition with digital alternatives from their home using devices they already own (i.e. smartphones and tablets). Kaia Health has enrolled more than 450,000 users to date in their digital therapy program. Kaia Health is a member of the Digital Therapeutics Alliance (DTA), an international non-profit trade association of industry leaders and stakeholders engaged in the evidence-driven advancement of digital therapeutics. Kaia has offices in New York and Munich. Learn more at www.kaiahealth.com Contact Details Hot Cherry PR Harry Cymbler harry@hotcherry.co.uk

February 10, 2021 07:00 AM Eastern Standard Time

Image

CMMC Center of Excellence Announces Engagement Agreement with Ignyte Assurance Platform

Interoperability Clearinghouse

The Cybersecurity Maturity Model Certification Center of Excellence ( CMMC COE ), hosted by the Information Technology Acquisition Advisory Council (IT-AAC), a public-private partnership serving the public and private sectors for more than 15 years, is excited to announce a partnership with Ignyte Assurance Platform, a leading provider of software and consulting expertise for cyber risk, cyber compliance, and cybersecurity standards mapping and assurance. This unique partnership will extend efforts to identify and include proven capabilities within the CMMC COE Marketplace to improve cybersecurity protection and resilience for the global defense industrial base network of contractors, vendors, and suppliers. Ignyte Assurance Platform delivers a software product to assist with data collection, analysis, and to help streamline processes across multiple security frameworks at once. The capability developed by Ignyte Assurance Platform supports an organization’s efforts around security, governance, risk management, and compliance and provides a tested and proven range of solutions to improve overall cybersecurity protection and resilience while meeting requirements of standards such as CMMC. The executed Engagement Agreement establishes a collaborative engagement between Ignyte Assurance Platform and the CMMC COE to partner in the furthering of their respective and complementary missions and objectives regarding the adoption, use, and expansion of CMMC based cybersecurity practices, risk management, and compliance for the DIB contractor, vendor, and supplier community of providers creating a broader CMMC ecosystem globally to improve security and resilience. “This is exciting opportunity for us”, said Mr. John Weiler, Chairman of the Board at CMMC Center of Excellence, “This new partnership will further help advance the goals and objectives for improving the supply chain security and resilience of the US Department of Defense (DoD)”. “While CMMC seems like a brand-new framework for someone outside the industry, we’ve been working on automation of its predecessor legislative and industry requirements such as DFARS 252.204-7012, NIST 800-171 and FedRAMP since 2012, eliminating manual components and automating governance processes” said Mr. Max Aulakh, Founder and CEO of Ignyte Assurance Platform. “We recommend implementing NIST 800-171 for now, because it’s the first logical step in CMMC adaptation. NIST domains cover 110 controls out of 130 required for Level 3 of CMMC. Joining IT-AAC / COE in this initiative, we are not just bringing educational resources to the table, but have the means to utilize our technology to speed up and simplify CMMC adoption for the DoD Supply Chain” Specific actions will include: The co-development of CMMC advisory services, cyber training and education programs to accelerate CMMC certification, increase cyber adoption and improve cyber protection & resilience. Co-sponsor symposiums, training programs and podcasts leveraging their combined cyber and IT expertise. Host regular working groups, with other partners, to enable collaboration and communications. Source qualified CMMC/ cyber professionals to serve as advocates. Establish an independent Industry Cyber Security Advisory Council with peer organizations to advise and educate leaders across government and industry on the continued evolution and effectiveness of CMMC. The CMMC-COE ( http://cmmc-coe.org ) and Ignyte Assurance Platform partnership will focus on bringing together the many disparate cyber and national security communities of interest to reduce complexity, improve awareness, and accelerate industry effort to become more cyber resilient against the growing threats from nation states and criminal enterprises. The CMMC-COE establishes both a Market Place and Knowledge Clearinghouse that will include resources that support the overall effort, including white papers; tutorials; recorded webcasts; presentations; and more that will help reduce the cost and burden on small and medium size contractors already struggling from the impact of COVID. For more information on the CMMC COE, please visit http://cmmc-coe.org email info@cmmc-coe.org or call 703-863-3766 For more information on Ignyte Assurance Platform, please visit https://ignyteplatform.com/ About Us ---------- CMMC-COE.ORG is a unique non-profit public-private partnership, with a vision to accelerate Cybersecurity Maturity Model (CMM) adoption, and reduce time & cost for security compliance for our partners by leveraging commercial best practices, CMMC standards, and innovative solutions for a measurable success. Our mission, focused on DOD mission objectives, cost containment and expeditious CMMC compliance, is to help the DIB improve cyber posture and resilience, and simplify its acquisition. The CMMC-COE is hosted by the Information Technology Acquisition Advisory Council (IT-AAC), a public/private partnership (P3) chartered in 2007 as an honest broker to reach outside the confines of the Federal IT advisories that lack dynamic reach into the Global IT Market, and dedicated to the adoption of commercial IT management standards of practice and innovations emanating from the Global IT market. Team IT-AAC has already demonstrated the value of its decade long investment, and provides a unique value to agencies seeking to achieve accelerate the transformation of legacy processes and systems. Our Just-in-Time SMEs apply an innovative suite of Technology Business Management and Agile Acquisition Processes needed to assure the business value of commercial IT. The Interoperability Clearinghouse (ICH), is the managing partner that make up the 24 NGO/SDO organizations that make up the IT-AAC. ICH provides the contract vehicles, clearances, and critical resources proven to guide sustainable, measurable and repeatable processes needed to drive better investment decisions as the speed of mission need, while aligning existing processes, methods and workforce with IT reform mandates contained in Clinger Cohen Act, FITARA, IT MGT Act, EO13838. Contact Details Bob Dix +1 703-975-6633 bob.dix@it-aac.org Company Website https://cmmc-coe.org

February 08, 2021 08:00 AM Eastern Standard Time

MarketFinance Business Booster Fund announces first winners of grants

Stockwood Strategy

Fintech business lender MarketFinance has today made three grants of £5,000 each to winners of the MarketFinance Business Booster Fund. Over 500 virtual pitches were received and 5 were shortlisted. These businesses were put to a social media vote before three winners were selected. The three winning entries came from ethical breastfeeding clothing brand The Bshirt, smart food labelling specialist BlakBear and independent children’s literacy charity The Economist Educational Foundation. Inner city young people’s charity XLP and creative agency Collaborative Creations were the other two businesses to make the shortlist. Anil Stocker, CEO of MarketFinance commented: “We launched this initiative as a small boost to help the successful businesses pivot, scale or grow in 2021. We want to support more of the UK’s hardest working and most exciting SMEs. In addition to the grant, we will offer the time and skills of our expert staff to help their leadership teams. Whether they need tech, marketing, finance or communications support, we will provide the resources to help them get to where they want to go. The winners' applications were highly commended and we wish them all the very best for the year ahead. ” On being the first beneficiaries of grants from the MarketFinance Booster Fund, the winners’ comments: Lisa Lessaware, co-founder of The Bshirt said: “This means so much to our business. This grant will be used to launch exciting new ethical products to help women breastfeed more comfortably and ultimately for longer.” Michael Kasimatis, co-founder at BlakBear said: “We’re thrilled to receive this grant. It will help drive the technical and regulatory development. Initiatives like this truly help deliver research and innovation to the market. Thank you, MarketFinance". Harriet Boland, Fundraising & Partnerships manager, at The Economist Educational Foundation said: “We are delighted to receive a grant from the MarketFinance business booster fund! This money will help us grow and reach thousands more young people and enable them to have inspiring discussions about current affairs in schools." The Business Booster Fund was established in December 2020 and forms part of a commitment from MarketFinance to SMEs. The Fund makes grants of £5,000 available to UK small businesses, along with expert advice from MarketFinance’s team. The fund has been designed to develop innovative entrepreneurs even further. MarketFinance looked for entrepreneurs that represent our community as a whole, and is keen to support companies that value diversity, inclusion and giving back. Anil Stocker added: “We know that the winners, and all SMEs in general, face challenging times as we deal with both the COVID-19 pandemic and the resulting economic challenges ahead. For that reason, it has been exciting to see a very wide range of innovative approaches from so many applicants to grow their businesses. It was difficult to narrow the awards down to a small number of outstanding winners and we look forward to supporting them with a variety of talent and resources at MarketFinance”. ENDS About MarketFinance MarketFinance is a business finance company with offices in London and Manchester. The online platform enables businesses to access a range of flexible finance solutions - quickly and easily. This smart technology is backed by help from real people so business owners can save time and focus on growing their business. Since 2011, MarketFinance has advanced over £3 billion to companies across a range of sizes and sectors, providing working capital and finance for everything from paying staff and suppliers to launching new products or services and accelerating growth. MarketFinance is backed by Barclays, Santander InnoVentures, European venture capital fund Northzone (invested in Klarna, iZettle and Trustpilot), and private equity group MCI Capital (also invested in iZettle, Azimo and Gett). Contact Details MarketFinance Bilal Mahmood +44 7714 007257 b.mahmood@marketfinance.com Company Website https://marketfinance.com/

February 03, 2021 08:00 AM Eastern Standard Time

Image

GRYT Health Celebrates Five Year Anniversary

GRYT Health

On February 4, 2021, GRYT (“grit”) Health, a digital oncology company that empowers people to be in charge of their own health, is celebrating its five-year anniversary. Launched in 2016 on World Cancer Day with a purpose of helping those with cancer avoid isolation, GRYT Health today has grown to offer support services through connection and education, as well as the ability for patients, survivors and caregivers to share their experiences through one of GRYT Health’s research projects to improve healthcare. “When we started GRYT Health five year ago it was out of loneliness and a deep-rooted desire to help other patients avoid the way we had felt let down and unsupported during our own experiences with cancer,” said Dave Fuehrer, co-founder and chief executive officer of GRYT Health and two-time cancer survivor. “Even as a patient experience researcher myself, I felt unequipped to navigate the intricacies of the patient journey and treatment regimen during my two battles with testicular cancer. I knew we had to do something to help others.” More than 10,000 people have downloaded the GRYT Health app, which today is also available on a desktop platform at www.grythealth.com, creating more than 1.3 million interactions on the GRY Health platform. Additionally, the GRYT Health website offers a host of resources, including articles on issues relevant to the cancer journey and is a place where community members are empowered to share their stories. Users can also access Vivibot, a mental health chatbot that listens, 24/7 on the platform. To learn more and create a free GRYT Health account, visit www.grythealth.com. Growing from four co-founders in 2016 to a staff of 14 (and growing!) today, GRYT Health is comprised of cancer survivors, caregivers and researchers. In addition to the app, the organization offers a number of virtual conferences, including the cornerstone Global Virtual Cancer Conference and the COVID Advocacy Exchange, which not only help to educate attendees, but provide a platform for sharing experiences. In total, GRYT Health has hosted more than 120 virtual conferences; highlighting 300 industry, patient, survivor, caregiver, researcher and providers as presenters; and uniting 11,000 people who have registered for a GRYT Health event. “I am so proud of the company GRYT Health has become today,” said Co-Founder and Chairwoman of GRYT Health, Shelley Nolden, who is also an AML survivor. “We are truly empowering our community of patients, survivors and caregivers to find and use their voice to elevate healthcare.” Currently, working in collaboration with half of the world’s top 10 pharmaceutical companies, GRYT Health also champions patient experience research and clinical trial recruiting. Through The GRYT Project, community members have the opportunity to participate in relevant, compensated research opportunities where they are able to share their experiences to improve quality of life and outcomes. Nearly 1,000 patients, survivors and caregivers have participated in a GRYT Health research project today. “For the past five years, we have followed three principles in everything we have done: permission, transparency and partnership,” said Darcy Flora, Ph.D., chief research officer. “As a company founded and run by cancer survivors and caregivers, we have a relentless focus on the patient experience and work with companies who do the same. It is an honor to share others’ experiences and we are thankful for the work that we do and the differences we can make in healthcare, together.” In celebration of GRYT Health’s five-year anniversary, and in recognition of all we have achieved because of our community, GRYT Health is hosting a virtual birthday celebration via Zoom on February 4, 2021 at 7 pm ET. All are welcome to the free event, which will include entertainment from Aaron O’Brien, comedic magician, the premiere of the GRYT Health impact video made from community member submissions, games and prizes. To learn more and register, visit www.grythealth.com. GRYT Health is a digital oncology company that empowers people to be in charge of their own health through education, engagement and support. We offer a community free from judgment that focuses on humanity and the value each person brings. Our mission is to improve quality of life and increase survival for people facing cancer through the relentless focus on patient experience. We put patients first and work with healthcare organizations that do the same. We use the patient voice to enhance drug development and access; and together, we are helping to move healthcare forward. Visit www.grythealth.com to learn more. Contact Details GRYT Health Nichole Owens +1 315-263-4618 nichole@grythealth.com Company Website https://www.grythealth.com

February 02, 2021 09:03 AM Eastern Standard Time

1 ... 285 286 287 288 289 ... 306